Summary
GlobalData's clinical trial report, “Acute Pain Global Clinical Trials Review, H1, 2016" provides an overview of Acute Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Acute Pain. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Reasons to buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Companies Mentioned
Mallinckrodt Plc
Pfizer Inc.
Johnson & Johnson
Merck & Co., Inc.
AcelRx Pharmaceuticals, Inc.
Cara Therapeutics, Inc.
Trevena, Inc.
Grunenthal GmbH
Lotus Clinical Research, LLC
Jaguar Holding Company II
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Acute Pain to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Acute Pain to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Acute Pain Therapeutics Clinical Trials 28
Prominent Drugs 30
Latest Clinical Trials News on Acute Pain 31
Mar 31, 2016: OFIRMEV (Acetaminophen) Injection Health Economic Data Presented at 41st Annual Regional Anesthesiology and Acute Pain Medicine Meeting 31
Mar 14, 2016: AcelRx Pharmaceuticals Advances ARX-04 into Extension Phase of Open-Label Phase 3 Emergency Room Study 31
Mar 07, 2016: AcelRx Pharmaceuticals Initiates Phase 3 Study of ARX-04 in Patients with Post-Operative Moderate-to-Severe Acute Pain 32
Feb 25, 2016: AcelRx Pharmaceuticals Moderate-to-Severe Acute Pain Candidate ARX-04 Shows Improved Pain Scores in ER Patients in Interim Phase 3 Analysis 32
Feb 19, 2016: KemPharm to Present Data From Oral Human Abuse Liability Study for Investigational Drug KP201/APAP at the 2016 AAPM Annual Meeting 33
Feb 11, 2016: AcelRx Pharmaceuticals Presents Phase 3 Results from ARX-04 Clinical Program at JAB Burn and Wound Care Symposium 34
Jan 21, 2016: AcelRx Pharmaceuticals Announces Presentation of Phase 3 Sufentanil Sublingual 30 mcg Tablet (ARX-04) Data at the European Congress of Ambulatory Surgery 34
Clinical Trial Profile Snapshots 35
Appendix 279
Abbreviations 279
Definitions 279
Research Methodology 280
Secondary Research 280
About GlobalData 281
Contact Us 281
Disclaimer 281
Source 282
List of Tables
Acute Pain Therapeutics, Global, Clinical Trials by Region, 2016* 6
Acute Pain Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 8
Acute Pain Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9
Acute Pain Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 10
Acute Pain Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 11
Acute Pain Therapeutics Clinical Trials, North America, Top Countries, 2016* 12
Acute Pain Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016* 13
Acute Pain Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2016* 14
Proportion of Acute Pain to Central Nervous System Clinical Trials, G7 Countries (%), 2016* 15
Acute Pain Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 16
Acute Pain Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 17
Proportion of Acute Pain to Central Nervous System Clinical Trials, E7 Countries (%), 2016* 18
Acute Pain Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 19
Acute Pain Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 20
Acute Pain Therapeutics, Global, Clinical Trials by Phase, 2016* 21
Acute Pain Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 22
Acute Pain Therapeutics, Global, Clinical Trials by Trial Status, 2016* 23
Acute Pain Therapeutics Clinical Trials, Global, by End Point Status, 2016* 24
Acute Pain Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 25
Acute Pain Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 26
Acute Pain Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 27
Acute Pain Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 29
Acute Pain Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 30
List of Figures
Acute Pain Therapeutics, Global, Clinical Trials by Region (%), 2016* 6
Acute Pain Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Acute Pain Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9
Acute Pain Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 10
Acute Pain Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 11
Acute Pain Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 12
Acute Pain Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016* 13
Acute Pain Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2016* 14
Proportion of Acute Pain to Central Nervous System Clinical Trials, G7 Countries (%), 2016* 15
Acute Pain Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 16
Acute Pain Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 17
Proportion of Acute Pain to Central Nervous System Clinical Trials, E7 Countries (%), 2016* 18
Acute Pain Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 19
Acute Pain Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 20
Acute Pain Therapeutics, Global, Clinical Trials by Phase (%), 2016* 21
Acute Pain Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 22
Acute Pain Therapeutics, Global, Clinical Trials by Trial Status, 2016* 23
Acute Pain Therapeutics Clinical Trials, Global, by End Point Status, 2016* 24
Acute Pain Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 25
Acute Pain Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 26
Acute Pain Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 27
Acute Pain Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 28
Acute Pain Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 30
GlobalData Methodology 280
